MRERX
Price
$51.90
Change
+$0.47 (+0.91%)
Updated
Jul 3 closing price
Net Assets
6.67B
VSMPX
Price
$281.45
Change
+$2.40 (+0.86%)
Updated
Jul 3 closing price
Net Assets
1.82T
Interact to see
Advertisement

MRERX vs VSMPX

Header iconMRERX vs VSMPX Comparison
Open Charts MRERX vs VSMPXBanner chart's image
MFS Core Equity R2
Price$51.90
Change+$0.47 (+0.91%)
VolumeN/A
Net Assets6.67B
Vanguard Total Stock Mkt Idx Instl Pls
Price$281.45
Change+$2.40 (+0.86%)
VolumeN/A
Net Assets1.82T
MRERX vs VSMPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MRERX vs. VSMPX commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRERX is a Buy and VSMPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 1.82T vs. MRERX (6.67B). VSMPX pays higher dividends than MRERX: VSMPX (1.22) vs MRERX (0.22). MRERX was incepted earlier than VSMPX: MRERX (22 years) vs VSMPX (10 years). MRERX (1.15) is less costly to investors than VSMPX (0.02). MRERX is a more actively managed with annual turnover of: 30.00 vs. VSMPX (2.00). MRERX has a lower initial minimum investment than VSMPX: MRERX (0) vs VSMPX (100000000). VSMPX annual gain was more profitable for investors over the last year : 13.90 vs. MRERX (4.61). VSMPX return over 5 years is better than : 95.69 vs. MRERX (56.55).
MRERXVSMPXMRERX / VSMPX
Total Expense Ratio1.140.025,700%
Annual Report Gross Expense Ratio1.150.025,750%
Fund Existence22 years10 years-
Gain YTD6.2006.42696%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.67B1.82T0%
Annual Yield % from dividends0.221.2218%
Returns for 1 year4.6113.9033%
Returns for 3 years38.6862.1762%
Returns for 5 years56.5595.6959%
Returns for 10 years89.23189.2147%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRIB0.750.07
+10.12%
Trinity Biotech plc
CATX3.680.29
+8.55%
Perspective Therapeutics
CGEN1.760.02
+1.15%
Compugen Ltd
STT110.310.82
+0.75%
State Street Corp
WHD45.270.01
+0.02%
Cactus